# Diagnostic Accuracy of DaTQUANT® Versus BasGanV2™ for 123I-Ioflupane Brain SPECT: A Machine Learning-Based Differentiation of Parkinson’s Disease and Essential Tremor

**Authors:** Barbara Palumbo, Luca Filippi, Andrea Marongiu, Francesco Bianconi, Mario Luca Fravolini, Roberta Danieli, Viviana Frantellizzi, Giuseppe De Vincentis, Angela Spanu, Susanna Nuvoli

PMC · DOI: 10.3390/biomedicines13102367 · Biomedicines · 2025-09-27

## TL;DR

This study compares two tools for analyzing brain scans to distinguish Parkinson's disease from essential tremor, finding one tool more accurate when combined with machine learning.

## Contribution

Demonstrates that DaTQUANT® outperforms BasGanV2™ in machine learning-based diagnosis of Parkinson’s disease versus essential tremor using SPECT imaging.

## Key findings

- DaTQUANT® achieved higher diagnostic accuracy (93.8-94.5%) than BasGanV2™ (90.9-91.9%) across machine learning models.
- Higher sensitivity and specificity were observed for DaTQUANT® compared to BasGanV2™ in differentiating Parkinson’s disease from essential tremor.
- Machine learning models reliably distinguished Parkinson’s disease from essential tremor when trained on SPECT imaging data.

## Abstract

Background: Differentiating Parkinson’s disease (PD) from essential tremor (ET) is often challenging, especially in early or atypical cases. Dopamine transporter (DAT) single-photon emission computed tomography (SPECT) with 123I-Ioflupane supports diagnosis, and semi-quantitative tools such as DaTQUANT® and BasGanV2™ provide objective measures. This study compared their diagnostic performance when integrated with supervised machine learning. Methods: We retrospectively analysed 123I-Ioflupane SPECT scans from 169 patients (133 PD, 36 ET). Semi-quantitative analysis was performed using DaTQUANT® v2.0 and BasGanV2™ v.2. Classification tree (ClT), k-nearest neighbour (k-NN), and support vector machine (SVM) models were trained and validated with stratified shuffle split (250 iterations). Diagnostic accuracy was compared between the two software packages. Results: All classifiers reliably distinguished PD from ET. DaTQUANT® consistently achieved higher accuracy than BasGanV2™: 93.8%, 93.2%, and 94.5% for ClT, k-NN, and SVM, respectively, versus 90.9%, 91.7%, and 91.9% for BasGanV2™ (p < 0.001). Sensitivity and specificity were also consistently higher for DaTQUANT® than BasGanV2. Class imbalance (PD > ET) was addressed using Synthetic Minority Over-sampling Technique (SMOTE). Conclusions: Machine learning analysis of 123I-Ioflupane SPECT enhances differentiation between PD and ET. DaTQUANT® outperformed BasGanV2™, suggesting greater suitability for AI-driven decision support. These findings support the integration of semi-quantitative and AI-based approaches into clinical workflows and highlight the need for harmonised methodologies in movement disorder imaging.

## Linked entities

- **Chemicals:** 123I-Ioflupane (PubChem CID 3086674)
- **Diseases:** Parkinson’s disease (MONDO:0005180), essential tremor (MONDO:0003233)

## Full-text entities

- **Genes:** SLC6A3 (solute carrier family 6 member 3) [NCBI Gene 6531] {aka DAT, DAT1, PKDYS, PKDYS1}
- **Diseases:** PD (MESH:D010300), ET (MESH:D020329), movement disorder (MESH:D009069)
- **Chemicals:** 123I-Ioflupane (MESH:C519528)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12561021/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12561021/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12561021/full.md

---
Source: https://tomesphere.com/paper/PMC12561021